Corporate News

2024

25 November 2024
Holding(s) in Company
01 October 2024
Holding(s) in Company
26 September 2024
Half-Year Report
24 September 2024
Holding(s) in Company
20 September 2024
Holding(s) in Company
12 September 2024
Notice of results
28 June 2024
Result of AGM
04 June 2024
Final Results for the Year Ended 31 December 2023 & Notice of AGM
22 May 2024
Notice of Results
10 May 2024
Holding(s) in Company
11 January 2024
Trading Update

2021

13 December 2021
Trading update
24 November 2021
Launch of COVID-19 Day 2 rapid antigen test and verification service
01 October 2021
Board Change
29 September 2021
Half-year Report
20 September 2021
Statement re. COVID-19 testing
17 September 2021
Statement re. COVID-19 testing
07 September 2021
Notice of Results & Q3 Trading Update, Investor Presentation
01 September 2021
Medical laboratory accreditation for COVID testing
24 August 2021
Statement re. DHSC press release
30 July 2021
Issue of equity/PDMR Dealing
07 July 2021
Trading update
29 June 2021
Result of AGM
28 June 2021
Acquisition of technology-led genetic testing platform and personalised nutrition company
04 June 2021
Notice of Annual General Meeting
04 June 2021
Board Changes
04 June 2021
Final Results
20 May 2021
Related Party Transaction
17 May 2021
Additional Boots agreement for Day 2 & Day 8 testing
06 April 2021
Directorate Change
06 April 2021
Agreement with Boots for COVID-19 sample kits
29 March 2021
Further COVID-19 Government testing approvals
09 March 2021
Holding(s) in Company
01 March 2021
Comment on Share Price Movement
24 February 2021
TR-1: Notification of major holdings
19 February 2021
Director/PDMR Shareholding
18 February 2021
Result of General Meeting
17 February 2021
Conditional Subscription - Update re HMRC Advance Assurance
01 February 2021
Posting of Circular
29 January 2021
Close of Accelerated Bookbuild and results of Fundraising
29 January 2021
Proposed fundraising to raise approximately £3 million at a price of 1.75p
25 January 2021
Comment on Share Price movement